awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33840949-F7FE4CC0-0620-4235-A2D9-3522CE2EA304
Q33840949-F7FE4CC0-0620-4235-A2D9-3522CE2EA304
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33840949-F7FE4CC0-0620-4235-A2D9-3522CE2EA304
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.
P2860
Q33840949-F7FE4CC0-0620-4235-A2D9-3522CE2EA304
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33840949-F7FE4CC0-0620-4235-A2D9-3522CE2EA304
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
206faef0b14dfbda5b2aa2bb048aefe191a4d416
P2860
Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product.